flow semaglutide trial in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical Media Centre | EASD
Description
Neither approach is inherently strongerboth rely on the same mechanism of action when dosed appropriately
Agree on clear criteria for when to contact your gastroenterology teamfor example, if you develop bloody diarrhoea, severe abdominal pain, or symptoms suggesting a UC flare
Liu BN, Liu XT, Liang ZH, Wang JH
Food choices influence lipid levels alongside medication effects
They provide very fast relief, often within minutes, but the effect usually only lasts for an hour or two
Nausea, vomiting, diarrhea, and constipation are common, especially during dose escalation, but typically decrease over time
